Company
CorTec
Freiburg, Germany neurotechnology company. Develops implantable brain-computer interfaces that record and stimulate neural activity.
1 story
Regulatory News has published 1 story about CorTec on 18 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 18 September 2026.
This page is generated from Regulatory News’ editorial coverage of CorTec. It is not an advertisement.
On the record
- Company
- CorTec GmbH (privately held)
- Headquarters
- Freiburg, Germany
- Regulator
- U.S. Food and Drug Administration (CDRH)
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
